MakeMyTrip Price Target Raised to $100.00/Share From $95.00 by B of A Securities
MakeMyTrip Analyst Ratings
Citi Maintains MakeMyTrip(MMYT.US) With Buy Rating, Raises Target Price to $115
Morgan Stanley Maintains MakeMyTrip(MMYT.US) With Buy Rating, Raises Target Price to $111
BofA Securities Maintains MakeMyTrip(MMYT.US) With Buy Rating, Raises Target Price to $100
TD Cowen Remains a Buy on Lantheus (LNTH)
TD Cowen Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $145
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $26
Lantheus Holdings Analyst Ratings
Jefferies Reaffirms Their Buy Rating on Lantheus (LNTH)
ARM Holdings Analyst Ratings
Morgan Stanley Upgrades ARM Holdings to Overweight, Raises Price Target to $190
Buy Rating on ARM Holdings: Strategic Edge AI Positioning Fuels Growth Outlook
Credit Suisse raised Arm's target price to $190.
Buy Rating Affirmed for Lantheus Holdings With Enhanced Revenue Projections and Strategic Expansion
Hims & Hers Health Analyst Ratings
Craig-Hallum Keeps Their Buy Rating on Hut 8 Mining Corp (HUT)
Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Raises Price Target to $145
TransMedics Gr Analyst Ratings
Morgan Stanley Boosts Price Target on TransMedics Group to $145 From $104, Keeps Equalweight Rating